Jeremy Hague
Company: Enzymlogic
Job title: Chief Business Development Officer
Seminars:
Kinetic Profiling of Reversible & Irreversible Kinase Inhibitors : At Scale & Speed 10:10 am
Why kinetic profiling matters in drug discovery Enzymlogic’s KINETICfinder® and COVALfinder® platforms: optimized for reversible and irreversible inhibitor kinetic profiling in early discovery Case studies that illustrate: How kinetic profiling reinforces drug discovery decision making Kinetic Selectivity is a superior predictor of efficacy compared to Affinity Selectivity How Enzymlogic supports your kinetic investigationRead more
day: Day Two